Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neurontin 300mg capsules
0408010G0BBABAB
|
Neurontin | Gabapentin | Central Nervous System | 1,898 |
|
Neurontin 100mg capsules
0408010G0BBAAAA
|
Neurontin | Gabapentin | Central Nervous System | 651 |
|
Neurontin 600mg tablets
0408010G0BBADAJ
|
Neurontin | Gabapentin | Central Nervous System | 418 |
|
Neurontin 400mg capsules
0408010G0BBACAC
|
Neurontin | Gabapentin | Central Nervous System | 408 |
|
Neurontin 800mg tablets
0408010G0BBAEAK
|
Neurontin | Gabapentin | Central Nervous System | 84 |
|
Neurontin 250mg/5ml oral solution
0408010G0BBAFAQ
|
Neurontin | Gabapentin | Central Nervous System | No data available |
|
Neurontin titration pack
0408010G0BBAGAX
|
Neurontin | Gabapentin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.